Operating in the field of pharmaceutical logistics SkyCell, $116 million received investment. 59 million dollars of this investment Tybourne Capital Management ve CCI It was done by. In the same period Catalystmade an equity investment of $57 million in the Switzerland-based company. SkyCell announced that the new investment will be used to develop supply chain technologies, market expansion and increase operational capacity.
in 2012 Richard Ettl ve Nico Ross Founded by SkyCell, it is positioned as a company that offers advanced technologies to protect the pharmaceutical supply chain. With its IP-protected temperature-controlled containers and advanced technology software, SkyCell maintains the temperature sensitivity of medicines, reducing the risk of spoilage during transit to almost zero, the company said. SkyCell’s lightweight and advanced technology containers reduce CO2, or carbon emissions, by up to 50 percent during transportation processes.
SkyCell’s SkyMind software improves supply chain management by providing real-time visibility and data analytics. Thus, pharmaceutical companies can make better decisions, reduce operational costs and make logistics processes more efficient.
The pharmaceutical industry is a constantly evolving field, playing a critical role in meeting the basic health needs of modern societies. SkyCell also protects the effectiveness and safety of medicines by providing temperature control during the transportation of medicines. Additionally, it supports environmental sustainability by reducing CO2, or carbon, emissions.
Source link: https://webrazzi.com/2024/06/25/ilac-lojistigi-girisimi-skycell-116-milyon-dolar-yatirim-aldi/